The Health and Social Care Committee has published a new report on Integrated Care Systems (ICSs), calling for the Government and NHS England to address key concerns if an opportunity to deliver real change is to be achieved.
Brevia Consulting has appointed Mike Thompson as Chairman of Brevia Health and a member of its Advisory Board. Mike brings over 25 years of experience in the Life Sciences sector including, most recently, as CEO of the Association of the British Pharmaceutical Industry (ABPI) and in senior roles at GSK. He also sits on the Life Sciences Advisory Board of the British Growth Fund. Mike will oversee Brevia Health, a dedicated division of Brevia Consulting, which offers a team of consultants with experience in pharmaceuticals, IT Health, in vitro diagnostics, medical devices and genomics. Brevia Health provides straightforward public affairs and public relations support to organisations operating in the highly regulated UK healthcare sector. Services include political monitoring, strategic advice, media relations, select committee training, and comprehensive stakeholder engagement programmes that encompass Westminster, Whitehall, Brussels, and the devolved administrations. In his role as CEO of the APBI (2016-19), Mike was intimately involved in ensuring that the UK could continue to supply medicines through any Brexit scenario, and worked in partnership with the DHSC to bring forward policy proposals to ensure the system would cope. He oversaw the negotiations which secured the pharmaceutical industry’s VPAS (Voluntary Pricing and Access Scheme), which replaced
